Thomas Ertveldt

Doctor in Medical Sciences

  • Laarbeeklaan 101

    1090 Brussels

    Belgium

  • Source: Scopus
  • Calculated based on number of publications stored in Pure and citations from Scopus
20192024

Research activity per year

Personal profile

Expertise

Thomas Ertveldt is a junior postdoc at the VUB’s Molecular Imaging and Therapy (MITH) research group. He recently concluded his doctoral studies revolving the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s) and immune imaging upon immune intervention. With his research, he aspires to improve knowledge and tools to increase patients response as well as reduce adverse effects to novel therapies such as TRT and immunotherapy.

Fingerprint

Dive into the research topics where Thomas Ertveldt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or